A DHEA-S result lands in your patient portal flagged red. You search the number. The first three results give you a vague reassurance, a supplement ad, and a forum thread. None of them tell you what actually matters — which is that the number you are looking at is age-dependent, context-dependent, and almost never interpretable in isolation.
Normal DHEA-S Levels by Age (Women)
These are typical reference ranges drawn from major US reference laboratories. Your individual lab may print slightly different cutoffs; the broad shape is consistent across labs.
| Age range | DHEA-S reference range (µg/dL) | Editorial note |
|---|---|---|
| 18–29 years | 145–395 | Peak years; values below 100 here warrant workup |
| 30–39 years | 65–380 | Wide range; early adrenopause begins |
| 40–49 years | 32–240 | Pre/perimenopausal transition; decline accelerates |
| 50–59 years | 26–200 | Postmenopausal baseline territory |
| 60–69 years | 13–130 | Most women now in lower half of adult range |
| 70+ years | 17–90 | Floor; symptom-driven decisions matter more than the number |
Composite ranges drawn from LabCorp and Quest Diagnostics reference data, May 2026. Specific assay methods affect absolute values; trends are consistent across methods.
Symptoms of Low DHEA in Women
Low DHEA-S does not produce a clean syndrome. The symptom cluster is broad and overlaps with thyroid disease, low estrogen, depression, and chronic fatigue:
- Persistent fatigue not relieved by sleep
- Reduced libido and sexual responsiveness
- Dry skin, reduced elasticity, slow wound healing
- Low mood, anhedonia, reduced sense of vitality
- Slow recovery from physical or emotional stress
- Reduced muscle strength and exercise tolerance
- Decreased bone mineral density on DEXA
- Vaginal dryness, particularly in perimenopausal women
The non-specificity is the point. A low DHEA-S in a woman with these symptoms warrants a comprehensive workup, not a unilateral DHEA prescription.
What Causes Low DHEA in Women?
- Normal aging. The single largest factor. DHEA-S declines steadily from the mid-20s onward.
- Chronic stress. Sustained HPA-axis activation suppresses adrenal androgen output.
- Adrenal insufficiency. Primary (Addison’s) or secondary (pituitary disease) — both reduce DHEA-S, often severely.
- Oral contraceptives. Can reduce DHEA-S by 30–50% through adrenal androgen suppression.
- Long-term corticosteroid therapy. Suppresses adrenal output, including DHEA.
- Hypopituitarism. Loss of ACTH drives loss of DHEA production.
- Autoimmune adrenalitis. Even before frank Addison’s presents, DHEA-S may drop early.
Symptoms of High DHEA-S in Women
Elevated DHEA-S typically produces androgenic symptoms because of conversion to testosterone in peripheral tissues:
- Acne, particularly cystic and along the jawline
- Hirsutism — facial hair, increased body hair
- Scalp hair thinning consistent with androgenetic alopecia
- Menstrual irregularity, oligomenorrhea, or amenorrhea
- Oily skin and scalp
- Reduced fertility
- Voice deepening (rare, suggestive of more severe elevation)
- Clitoromegaly (rare, suggestive of more severe elevation)
The presence of voice changes or clitoromegaly with elevated DHEA-S is an automatic indication for imaging to rule out an adrenal source. Most cases of mild-to-moderate elevation, however, point toward functional causes — most commonly PCOS or non-classical CAH.
What Causes High DHEA-S in Females?
- Polycystic ovary syndrome (PCOS). Roughly 20–30% of women with PCOS have elevated DHEA-S; the rest have normal adrenal androgens with elevated ovarian androgens.
- Non-classical congenital adrenal hyperplasia (NC-CAH). A milder form of CAH that often presents in adolescence or early adulthood with elevated DHEA-S and 17-hydroxyprogesterone.
- Adrenal adenoma or carcinoma. Uncommon, but always considered in cases of marked elevation (typically above 700 µg/dL in adult women) or rapid symptom onset.
- Cushing syndrome (some variants). Particularly ACTH-driven Cushing’s.
- DHEA supplementation overdose. Extremely common and entirely reversible. Always ask about supplements before pursuing further workup.
How to Treat High DHEA in Females
The treatment approach depends entirely on the underlying cause — which is why “treat the number” is the wrong frame.
If the cause is PCOS
First-line interventions target the broader endocrine picture: lifestyle and weight management where relevant, insulin sensitizers (metformin) in some patients, combined oral contraceptives for cycle regulation, and anti-androgens (spironolactone) for symptomatic management.
If the cause is non-classical CAH
Low-dose glucocorticoid replacement (typically hydrocortisone or prednisone) suppresses the pathway. Treatment is individualized based on whether the goal is symptom control or fertility.
If the cause is supplementation
Stop the DHEA supplement. Retest in 6–8 weeks. The vast majority of OTC-DHEA-driven elevations resolve completely.
If the cause is an adrenal mass
Endocrinology and often endocrine surgery referral. This is a small minority of cases but the workup pathway is non-negotiable.
How to Raise Low DHEA Naturally
Evidence-based natural approaches have small effect sizes but are appropriate first-line steps before considering supplementation:
- Resistance training. Multiple observational and small intervention studies show modest DHEA-S increases with consistent strength training, particularly in postmenopausal women.
- Sleep optimization. Adequate, consistent sleep supports adrenal rhythm. Chronic short sleep suppresses DHEA-S over time.
- Chronic stress reduction. Meditation, yoga, and structured stress-management interventions have modest documented effects on DHEA-cortisol ratio.
- Micronutrient adequacy. Magnesium, zinc, and vitamin D deficiencies are associated with lower DHEA-S; correcting deficits is a reasonable baseline step.
- Avoid known suppressors. If you can discontinue corticosteroids or change contraceptive method without compromising other health priorities, that addresses an iatrogenic cause.
When Natural Methods Aren’t Enough
The honest reality: lifestyle interventions can move DHEA-S modestly but cannot restore youthful levels in an aging adrenal cortex. For women with documented adrenal insufficiency, replacement (with pharmacy-compounded oral DHEA prescribed by a clinician) is supported by guidelines. For women with normal adrenal function and age-appropriate decline, the case for replacement is weaker and the appropriate decision is individual.
For women whose symptoms are driven by low local hormone production — vaginal atrophy, dyspareunia — the most direct intervention is local: prescription vaginal Prasterone, which delivers DHEA where it is needed without raising systemic levels. This is one of the cleanest applications of DHEA in modern clinical care.